Please login to the form below
biotech funding
This page shows the latest biotech funding news and features for those working in and with pharma, biotech and healthcare.
Parkinson’s UK and Domainex announce new collaboration
Parkinson’s Virtual Biotech plans to invest up to £3m in the project. ... Virtual Biotech provides funding for research projects with scientific potential to help those living with Parkinson's.
Latest news
-
Novavax gets $1.6bn from US government for coronavirus vaccine
Latest company to join Operation Warp Speed. The US government has committed a massive $1.6bn in funding to late-stage biotech company Novavax for the accelerated development of its investigational ... So far, that funding has gone to six companies,
-
UK biotech funding falls 40% between 2018 and 2019
Despite funding falling down in the UK in 2019, the BIA noted that this drop in biotech investment was replicated in most regions across the globe. ... Although the US continues to attract most of the global investment for biotech, it also saw a drop of
-
Mega-mergers dominate as buoyant markets lift biopharma
The biotech has also managed to increase its share price since its launch, a feat not frequently achieved in the sector. ... Venture capital is also fuelling biotech funding, with $3bn raised in Q2.
-
BioNTech raises €290m for mRNA cancer vaccine platform
The bumper Series B comes 18 months after BioNTech raised $275m in first-round financing, and takes the total funding raised by the biotech to around $1.4bn. ... BioNTech was the first biotech to bring an mRNA-based individualised cancer vaccine
-
$450m diagnostics sale will fuel more Syncona biotech funding
immunotherapy biotech Achilles. ... These are expected to receive the final tranches of already committed funding, with more expected to follow.
More from news
Approximately 1 fully matching, plus 33 partially matching documents found.
Latest Intelligence
-
European biotech: a new generation of leaders emerges
Beside problems with funding and management models, one of European biotech’s problems so far has been that companies have been bought out early – illustrated last year by the $4.8bn ... However 2019 has seen some promising signs on this front.
-
Biopharma's Future: Made in China
Venture capital funds based in China invested $1.4bn into private US biotech firms in the first three months of 2018, accounting for about 40% of the $3.7bn raised in ... In terms of biotech funding, the emergence of Hong Kong’s stock market could
-
Pharma deals in March 2015
One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich. ... The Morphosys story highlights the uncertainty of funding for European biotech companies.
-
Small diseases need big picture communications
Small pharma or biotech may struggle with funding for communications early on in the development process, while larger pharma may be held back by slow processes that are embedded in a ... May need to travel long distances for care. Difficulties in
-
Interview: Steve Bates, BIA
The CEO of the BioIndustry Association discusses the state of UK biotech, its shared ecosystem with pharma and the funding challenges biotech faces. ... And that's really why getting the investment right for UK biotech is increasingly important.”.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Biotech Innovation in the Time of COVID-19
Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI &machine learning, and much more!
-
Newcells Biotech secures over £5m for 3D tissue models
Newcastle-based human stem cell model specialists, Newcells Biotech, have secured a total of £5.25m worth of funding to accelerate their growth plans in the international life sciences market. ... This funding round will help Newcells Biotech expand
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
